Yang-Xin Fu
Affiliations: | Immunology | University of Chicago, Chicago, IL |
Area:
Immunology, Microbiology BiologyGoogle:
"Yang-Xin Fu"Children
Sign in to add traineeRobert K. Chin | grad student | 2004 | Chicago |
James C. Lo | grad student | 2004 | Chicago |
Sumit K. Subudhi | grad student | 2004 | Chicago |
Sarah E. Blink | grad student | 2006 | Chicago |
Sogyong L. Auh | grad student | 2009 | Chicago |
Mendy L. Miller | grad student | 2010 | Chicago |
Jeremy O'Sullivan | grad student | 2011 | Chicago |
Byron C. Burnette | grad student | 2012 | Chicago |
Tony C. Tu | grad student | 2013 | Chicago |
Vaibhav Upadhyay | grad student | 2013 | Chicago |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang J, Li S, Wang M, et al. (2024) STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity. Biorxiv : the Preprint Server For Biology |
Wang X, Liu L, Yue T, et al. (2023) Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8 T cells. Signal Transduction and Targeted Therapy. 8: 268 |
Moore C, Bae J, Liu L, et al. (2022) Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity. Jci Insight. 7 |
Feng Q, Liu Z, Yu X, et al. (2022) Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nature Communications. 13: 4981 |
Li F, Zhang H, Wang W, et al. (2022) T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies. Nature Communications. 13: 4334 |
Lee KM, Lin CC, Servetto A, et al. (2022) Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple negative breast cancer. Cancer Immunology Research |
Li H, Liu Z, Liu L, et al. (2022) AXL targeting restores PD-1 blockade sensitivity of mutant NSCLC through expansion of TCF1 CD8 T cells. Cell Reports. Medicine. 3: 100554 |
Liu L, Chen J, Zhang H, et al. (2022) Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity. Nature Cancer |
Xue D, Moon B, Liao J, et al. (2022) A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors. Science Immunology. 7: eabi6899 |
Liu L, Chen J, Bae J, et al. (2021) Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells. Nature Biomedical Engineering |